About us

Claudia Rinnofner earned her PhD at Graz University of Technology (TUG) in the research group of Prof. Anton Glieder at the Institute of Molecular Biotechnology. Her PhD thesis focused on the production of recombinant proteins in Pichia pastoris employing synthetic promoters. She has more than 20 years of experience as a scientist, working with Pichia pastoris and strain engineering, including the production of various heterologous proteins. She worked at the Austrian Centre of Industrial Biotechnology as a scientist, and as a project leader at the company bisy. At the end of 2020, Claudia founded myBIOS with the ambition to advance industrial biotechnology by delivering innovative, scalable solutions for efficient and sustainable protein production.

Tamara Wrießnegger holds a PhD in Biochemistry from Graz Technical University. She brings over 15 years of experience as a researcher and project manager at the Austrian Centre of Industrial Biotechnology, and contributed to numerous projects focused on metabolic engineering of Pichia pastoris and the development of whole-cell biocatalysts for the production of high-value compounds. She has co-authored over 15 scientific publications and contributed to two patent applications. Since joining myBIOS in 2025, Tamara has been driving the company’s innovation strategy, applying her expertise in molecular and cell biology, bioreactor cultivations, enzyme engineering, and applied biotechnology to advance breakthrough solutions.

Alexandra Deibuk has a bachelor’s degree in Molecular Biology and a master’s degree in Biochemistry and Molecular Biomedicine. She did her masters thesis at Graz University of Technology in collaboration with myBIOS focusing on the production of the SARS-COV2 spike protein and a horseradish peroxidase conjugate in Pichia pastoris, thereby making the first steps towards a novel independent methanol-free protein production technology. Alexandra joined myBIOS in 2021. She is currently working as Lab-Team Leader at myBIOS.

Lukas Schönleitner has a bachelor’s degree in Molecular Biology and a masters’ degree in Biotechnology. He did his master thesis at Graz University of Technology (TUG) in the group of Birgit Wiltschi focusing on the integration of non-canonical amino acids in the model organism Saccharomyces cerevisiae and Escherichia coli. Lukas joined myBIOS in 2024. His focus is on exploring new approaches to overcome bottlenecks in methanol-free protein production in Pichia pastoris.

Daniela Gstattmann studies Biochemistry and Molecular Biomedicine. During her Bachelor’s thesis at the University of Graz, Institute of Biophysics, she was involved in the efficient isolation of integral membrane proteins in nanodiscs. Her strongest interest lies in applied biotechnology, especially in genetics and cloning. At myBIOS she focuses on developing novel platform tools. 

Alua Khairzhanova studies Molecular Microbiology as well as Biochemistry and Molecular Biomedicine. In her Bachelor’s thesis she compared the solubilization efficiencies of Nanodisc-forming surfactants for membrane proteins. She has experience in CRISPR-Cas9 genome editing. At myBIOS she focuses on implementing an alternative CRISPR approach. 

Sandra Flecker studied Molecular Biology, Biochemistry and Molecular Biomedicine at University of Graz. She joined myBIOS in 2021. Prior to it she was working in a diagnostics company. She is an experienced scientist, specialised in the field of Pichia pastoris.

Alexander Gutmann has 15 years of experience in biotechnology research and development. He managed development and optimization of fermentation and downstream processes, and organized scale-up to piloting and commercial manufacturing in the CDMO industry. He has also a strong academic track record in biocatalysis and related fields. Alexander joined myBIOS in 2024. Since 2025 he is supporting myBIOS as an independent consultant.